Florian Guisier

24PUBLICATIONS
62CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 24, 2026
Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study.

|Sep 10, 2026
The experiences and satisfaction of patients in outpatient cancer clinics: A scoping review.

|Jan 08, 2026
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis.

Mariano Provencio, Mark M Awad, Jonathan D Spicer

|Aug 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study).

Renaud Descourt, Florian Guisier, Maurice Pérol

|May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial.

Tina Cascone, Laura Bonanno, Florian Guisier

|Jun 05, 2024
Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.

Mateo Sanchis-Borja, Florian Guisier, Aurélie Swalduz

Pageof 4

Frequent Collaborators

9 joint publications

Christos Chouaid

6 joint publications

Nicolas Piton

5 joint publications

Jean-Bernard Auliac

3 joint publications

Olivier Bylicki